Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease.
Shinji KobaNoriyuki SatohYasuki ItoYuya YokotaFumiyoshi TsunodaKoshiro SakaiYuya NakamuraMakoto ShojiTsutomu HiranoToshiro ShinkePublished in: Clinical chemistry (2024)
Higher D-sdLDL-C can predict long-term recurrence of CAD in stable CAD patients independently of apoB and non-HDL-C. D-sdLDL-C is an independent risk enhancer for secondary CAD prevention, whereas E-sdLDL-C is not. UMIN-CTR Clinical Trial Number: UMIN000027504.
Keyphrases
- coronary artery disease
- clinical trial
- end stage renal disease
- percutaneous coronary intervention
- cardiovascular events
- coronary artery bypass grafting
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- transcription factor
- type diabetes
- study protocol
- open label
- cardiovascular disease
- aortic stenosis
- binding protein
- left ventricular
- phase ii